** Aphria’s U.S.-listed shares rise 7.3 pct premarket after special committee concludes acquisition of LatAm assets was within acceptable range vs. similar deals by rivals
** Co says review involved independent physical inspection of operating LatAM assets, confirming facilities, licenses and employment; committee recommended governance enhancements
** A short-seller in early December had questioned the deals and said they appeared “largely worthless,” leading Aphria to form a special committee
** Since then APHA has risen ~15 pct, while the Horizons Marijuana Life Sciences Index ETF has gained ~17 pct and the U.S.-listed ETFMG Alternative Harvest ETF is up 19 pct
** Cronos has surged ~127.5 pct, Canopy Growth ~37.5 pct and Aurora Cannabis ~24 pct, while Tilray has shed ~25 pct (Reporting by Savio D’Souza)
Our Standards: The Thomson Reuters Trust Principles.